Discontinuation rate of dual antiretroviral therapy with dolutegravir plus lamivudine in people living with HIV: a systematic review. Research, Society and Development, [S. l.], v. 11, n. 12, p. e430111234758, 2022. DOI: 10.33448/rsd-v11i12.34758. Disponível em: https://rsdjournal.org/rsd/article/view/34758. Acesso em: 6 dec. 2025.